comparemela.com

BOULDER, Colo.--(BUSINESS WIRE)--$BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has designated the Nodify CDT® Test as an Advanced Diagnostic Laboratory T...

Related Keywords

Scott Hutton ,Robbie Lunt ,Biodesix Inc ,Centers For Medicare Medicaid Services ,Nasdaq ,Laboratory Test ,Medicaid Services ,Advanced Diagnostic Laboratory Test ,Protecting Access ,Medicare Act ,Medicare Administrative Contractor ,Nodule Risk Assessment ,Artificial Intelligence ,Private Securities Litigation Reform Act ,Risk Factors ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.